Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric studyChristophe Passot, Philippe Gatault, Betoul Schvartz et al.|British Journal of Clinical Pharmacology|2020Cited by 15
Eculizumab dose tapering should take into account the nonlinearity of its pharmacokineticsOlivier Le Tilly, David Ternant, Philippe Gatault et al.|British Journal of Clinical Pharmacology|2024Cited by 4